Enspire DBS Therapy

Focus: Enspire DBS Therapy is a Cleveland-based biotech company focused on deep brain stimulation (DBS) technology for stroke recovery, operating at the intersection of neurology and cardiovascular medicine.

Neurology Cardiovascular

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Open Jobs

About Enspire DBS Therapy

AI assessmentNot Hiring

No open roles listed right now. Follow Enspire DBS Therapy to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Deep Brain Stimulation

Stroke

N/A

Clinical Trials (1)

NCT02835443Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke

N/A

Help build intelligence for Enspire DBS Therapy

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

First-mover opportunity in an emerging neuromodulation application (DBS for stroke recovery) with significant unmet clinical need
Focused pipeline targeting high-impact therapeutic areas (neurology and cardiovascular) with potential for accelerated approval pathways
Early-stage environment offers hands-on involvement in translational research and clinical development from ground level

Watch Out For

No active job openings and minimal public data on company size, funding, or development stage suggest early runway or dormant status
Complete absence of pipeline data, publications, and clinical trials raises questions about development progress and commercialization timeline
Pre-revenue status with unknown funding presents salary, equity liquidity, and financial sustainability risks

Generated by Claude from Enspire DBS Therapy's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Deep Brain Stimulation

Stroke

N/A

Clinical Trials (1)

NCT05701280Pilot/Pivotal Study of DBS+Rehab After Stroke

N/A

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Top TAs: Neurology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Neurology

2 pipeline

Marketed

Pipeline